Ph.D. - Developmental and Reproductive Biology
Permanent URI for this collection
Browse
Recent Submissions
Item Selenoprotein I is essential for proper central nervous system development: A study on ethanolamine phospholipid deficiency in oligodendrocyte development and function(2024) Nunes, Lance Gregory A.; Hoffmann, Peter R.; Developmental & Reproductive BiologyItem IDENTIFYING THE MOLECULAR FUNCTION OF MOUSE ZFY1 AND ZFY2 IN MALE REPRODUCTION(2024) Holmlund, Hayden Robert; Ward, Monika A.; Developmental & Reproductive BiologyItem DEFINING THE ROLE OF IRON-DEPENDENT CELLULAR INJURY IN CARDIOMYOCYTES(2024) Kawasaki, Nicholas Kaulike; Matsui, Takashi; Developmental & Reproductive BiologyItem ENGINEERED RECOMBINASES: TOOLS FOR THERAPEUTIC HUMAN GENOME EDITING.(2024) Sato, Ryuei; Owens, Jesse B.; Developmental & Reproductive BiologyItem The Effects of the FOXO3 Longevity Associated Variant on Biomarkers of Aging and Stress(University of Hawaii at Manoa, 2022) Torigoe, Trevor; Allsopp, Richard; Developmental & Reproductive BiologyThe Forkhead Box O3 (FOXO3) protein is one of four transcription factors that make up the FOXO family. The FOXOs are the mammalian homologues of the Caenorhabditis elegans daf-16 gene which has been associated with longevity. The four mammalian isoforms, FOXO1, -3, -4, and -6 are differentially expressed in various tissues. FOXO3 is expressed throughout the body, most significantly in the heart, brain, liver, muscle, spleen, testes, ovaries, and resident stem cells. Previous studies have shown that FOXO3 is positioned as a key regulator in multiple longevity regulatory pathways although the specific mechanisms are not well understood. We developed studies to explore the possible effect of the longevity-associated FOXO3 rs2802292 allele on age related change in telomere length, telomerase activity, FOXO3 gene expression, and plasma pro- and anti-inflammatory cytokine levels. The general hypothesis is that the FOXO3 longevity-variant is associated with increased FOXO3 expression, elevated levels of established healthy aging biomarkers, and reduction in biomarkers of stress response. In the initial study, Okinawa Study #1, telomere length and telomerase activity were assessed with respect to age as a function of both FOXO3 rs2802292 longevity associated variants and APOE variants in a population of Okinawan-Japanese. 121 subjects from Okinawa, Japan, ranging in age from 21-95 years, were recruited during annual physical appointments, where after consent, peripheral circulatory blood was collected and sent to the John A. Burns School of Medicine at the University of Mānoa for work-up and analysis. Telomere length was assessed in mononuclear cells using Southern blot analysis and telomerase activity was analyzed using the telomere repeat amplification protocol (TRAP). FOXO3 genotyping of the rs2802292 variant was performed using amplification-refractory mutation system allele-specific PCR while genotyping of the Apolipoprotein E variant done by standard PCR amplification and restriction enzyme digestion. We found that carriage of the FOXO3 G-allele was associated with protection against telomere loss with respect to age compared to those lacking the G-allele (TT-carriers). Importantly, this effect was only observed in subjects of middle age (arbitrary cut off of 50) and older. We did not detect an effect of carriage of the G-allele on telomerase activity in this preliminary study. In contrast, carriage of neither the ϵ4 -allele (risk allele) nor the ϵ2 -allele (protective allele) of APOE were associated with an effect on telomere attrition with respect to age. To further our analysis from our first study, we initiated a second larger Okinawa study (Okinawa Study #2), to assess telomere length, telomerase activity, FOXO3 gene expression, and circulatory plasma cytokines IL-1β, IL-2, IL-6, IL-10, and TNFα. We recruited 325 Okinawan Japanese subjects with roughly equal numbers of men and women (ages 19-104 years; 49:51 M:F ratio). FOXO3 genotyping, and telomerase activity was assessed using the same protocols as in the first study. Telomere length was analyzed using a monochrome multiplex quantitative PCR, FOXO3 gene expression was analyzed by quantitative PCR, and cytokine levels were assessed using a Milliplex MAP Human High Sensitivity T Cell Panel on a Luminex 200 system. In agreement with our previous findings, the FOXO3 longevity variant conferred protection against telomere shortening in peripheral blood mononuclear cells from adult aged 55 and older in both men and women (P<0.001). This was accompanied by higher levels of telomerase activity in carriers of the longevity-associated FOXO3 G-allele (P=0.015). Carriage of the FOXO3 G-allele was associated with a modest increase in FOXO3 gene expression in both young and old groups compared to decreased gene expression in TT-carriers, the difference in trend being most significant in the young population (P=0.02). We also observed two sex-specific protective effects of the FOXO3 rs2802292 G-allele in the older population with respect to inflammatory cytokine levels. In women, carriers of the G-allele displayed a modest decline in levels of pro-inflammatory cytokine IL-6 with respect to age in contrast to increasing levels with age in TT-carrier counterparts (P=0.07). This protective effect in maintaining lower levels of pro-inflammatory cytokines was highly significant in comparison to G-carrier men (P=0.0006). For the anti-inflammatory cytokine IL-10, G-carrier men in the old population retained IL-10 levels with age better than TT-carriers (P=0.04), and even more significantly compared to G-carrier women (P=0.007). Finally, in a collaborative study with Exeter University, we analyzed the expression of the FOXO3 isoform levels in peripheral blood using TaqMan PCR. Using a limited subset of RNA samples from the Okinawa Study#2 population, we were unable to find a significant effect of the longevity associated FOXO3 rs2802292 genotype on moderating levels of FOXO3-FL (full length) and FOXO3-TR (truncated) isoforms, although a trend towards increased expression in G-allele carriers was observed. Collaborators at the University of Exeter analyzed peripheral blood samples from the UK BioBank with respect to the FOXO3 rs13217795 longevity-associated SNP that is in linkage disequilibrium with the rs2802292 SNP. They found that carriage of the longevity-associated “C”-allele was associated with increased expression of the full-length isoform in peripheral blood as compared to TT-carriers. Truncated isoform expression was not observed in peripheral blood samples in either the Okinawan or UK BioBank cohorts. Through these findings, we believe that we have developed a foundation for FOXO3 and aging research that will provide an infrastructure to further life science and medical research in numerous specialties that will ultimately improve our understanding of healthy aging and further the development and technologies available to help patients in doing so.Item Adaptative Functions Of Sensory And Behavior Laterality In Astyanax Mexicanus(University of Hawaii at Manoa, 2021) Lima Fernandes, Vânia Filipa; Yoshizawa, Masato; Developmental & Reproductive BiologyLaterality consists of the asymmetrical use of the left or the right side in terms of morphology (the asymmetrical disposition of visceral organs), behavior (left or right-handedness), and neural processing. For example, regarding neural processing in humans, the left side of the brain is more often associated with analytical reasoning, while the right-side hemisphere is associated with emotion-processing tasks. Laterality is widely reported across vertebrates and several studies demonstrate that it confers a variety of advantages, such as performing intricate motor activities, spatial learning, cognitive and multitasking abilities, and escaping from predators. However, there is a major gap regarding how laterality arose through the course of evolution. Astyanax mexicanus, commonly known as the blind cavefish, has been presented as an excellent vertebrate model to study evolutionary processes. This teleost species is composed of two morphs: an eyed, river-dwelling surface morph (surface fish) and a blind cave-dwelling morph (cavefish). Sensory-behavior laterality has been described for cavefish regarding the detection of novel immotile objects. Cave-dwelling morphs have evolved different foraging strategies, such as attraction to a source of water disturbance/vibration, which is associated with the enhancement of non-visual sensory systems. This behavior is advantageous for capturing prey in the dark. Vibration Attraction Behavior (VAB) is a foraging behavior differently expressed in cave and surface morphs. Cavefish approaches the vibrating rod significantly more than surface fish, showing that cave individuals have a higher VAB level in comparison with the surface counterpart. Prey-capture assays have shown that cavefish (VAB positive) outcompeted surface fish (VAB negative) in the dark, which indicates that this foraging behavior may be crucial for survival in a cave environment. Further studies have demonstrated that VAB is mediated by the Lateral Line system, more precisely by the mechanosensory units present at the third infraorbital bone (IO3) region. The IO3 bone shows a higher degree of asymmetrical patterning and fragmentation across different cavefish populations. Furthermore, studies in zebrafish have reported an association between bone formation and neuromasts disposition during embryonic development. We will first investigate if the bone formation and consequently mechanosensory development at the IO3 region influence VAB output, and we will address if this sensory-behavior system exhibits laterality (Chapter 2). Additionally, we will discriminate both sensory and behavior laterality across different populations of Astyanax mexicanus, and we will functionally assess the asymmetric contribution of the mechanosensory system towards VAB (Chapter 3). Finally, we will address this foraging behavior lateral/asymmetrical modality in response to starvation (Chapter 3). Our results indicate that mechanosensory asymmetrical usage and behavior laterality vary according to food availability and across different cave populations over time. The most diversified cave population showed a combination of sensory and behavioral laterality, suggesting a novel advantage as a strategy to save energy in food-limited environments.Item Three-dimensional Mouse Stem Cell-derived Gastruloids: An In Vitro Approach To Study The Impact Of Teratogens During Gastrulation(University of Hawaii at Manoa, 2021) Li, Aileen S.; Marikawa, Yusuke; Developmental & Reproductive BiologyTeratogens are harmful chemical, physical or biological environmental exposure to childbearing and pregnant women that can increase the incidences of birth defects. To minimize the incidences of birth defects, it is important to identify teratogenic agents. However, there is no easy and reliable test to screen for teratogenic effects of substances. Epidemiologic studies in human are only retrospective, relying on hundreds of tragic incidences that had already happened to attain statistically sound conclusions, whereas experimentations using live animals are costly, laborious and associated with ethical issues. To compensate for these caveats of in vivo studies, in vitro teratogen tests using pluripotent stem cells are explored. Pluripotent stem cells can self-renew in culture indefinitely while retaining the developmental ability of early embryos. They can be induced to differentiate in vitro to mimic key aspects of embryogenesis, which may be used to evaluate the adverse effects of teratogenic exposures. The goal of my dissertation project is to validate one such stem cell-based in vitro embryogenesis model and apply it to elucidate the molecular mechanisms of some known teratogenic agents. First, we demonstrated that the morphogenesis and gene expression profile of the 3D stem cell model, known as the P19C5 gastruloid, are regulated by the same molecular machineries that function during early stages of normal embryogenesis, when body axis elongation and patterning take place. Second, we identified the molecular mechanisms, by which anti-epileptic medication, valproic acid, exerts its teratogenic effects through enhanced activation of retinoic acid signaling. Third, we revealed that methoxyacetic acid, the major metabolite of industrial products, including plasticizers and organic solvents, also enhance retinoic acid signaling to cause its adverse effects. Based on my dissertation project, we expect P19C5 gastruloid can serve as an effective in vitro model to assess the teratogenic potential of environmental exposures that may cause birth defects and explain the mechanisms of teratogenic agents to reduce the incidences of tragic birth defectsItem Evaluating Endogenous Carbon Monoxide (co) Production As An Indicator For Pulmonary Function Testing (PFT)(University of Hawaii at Manoa, 2019) Kim, Jung Eun; Titchenal, Charles A.; Developmental & Reproductive BiologyChronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, are associated with considerable morbidity and mortality in the United States. COPD is currently the 4th leading cause of death in the United States and a major cause of morbidity. More than 26 million Americans have asthma, which accounts for 14.2 million doctor’s office visits each year, according to the Centers for Disease Control and Prevention (CDC). These lung diseases involve chronic inflammation and oxidative stress. However, the diseases are not diagnosed and treated efficiently in routine clinical practice because of the difficulties in monitoring inflammation. Consequently, it is often too late to alter respiratory dysfunction when patients’ referral for pulmonary function testing is delayed. The purpose of this descriptive-correlational study was to explore the possible associations between pulmonary function test (PFT) measurements and exhaled carbon monoxide (eCO) levels as an indicator of generalized inflammation. Data analysis was conducted to determine a potential level of eCO to use as an indicator for conducting PFT. The contributions of demographic factors, patient history of smoking habits and drug use, and the medical diagnosis to the prediction of principal variables were also investigated. A sample of 343 subjects, who were referred by their physicians for a routine care PFT, were recruited from the Queen’s Medical Center Pulmonary Lab in Honolulu, Hawaii. A study-specific information sheet was provided to the subjects as part of the informed consent process, and the subjects’ data were collected through a Demographic Data Questionnaire. Exhaled carbon monoxide (eCO) levels were measured with a portable carbon monoxide analyzer (MicroCO Meter), and the maximum values from three successive measurements were used in all calculations. Carbon monoxide was detectable and measured reproducibly in the exhaled air of all subjects. Forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), FEV1/FVC, and forced expiratory flow 25-75% (FEF25-75%)) decreased with elevated concentrations of eCO. In females, decreased lung volumes (total lung capacity, functional residual capacity, and residual volume) were associated with increased eCO levels. In males, increased lung volumes were associated with increased eCO levels. Diffusion capacity of lungs for carbon monoxide (DLCO) and eCO levels also showed the opposite correlation between females and males. DLCO of female subjects markedly decreased with increased levels of eCO while DLCO of male subjects mildly increased. Appropriate cut-off points of eCO levels also were examined to determine the most efficient use of eCO as an indicator for PFT. The present study found that a cut-off point for eCO of 6 ppm provided the best relationship between sensitivity and specificity in predicting the need for PFT. In conclusion, eCO measurement, which is noninvasive, quick, inexpensive, and easily administered by primary care physicians, could serve as a useful biomarker for monitoring patients with pulmonary diseases. Therefore, eCO measurement may be clinically useful as a diagnostic tool to identify inflammation and to serve as an indicator of the need to conduct PFT.Item In vitro Morphogenesis in Developmental Toxicity Testing: Assay Validation and the Search for Teratogenic Mechanisms(University of Hawaii at Manoa, 2018-05) Warkus, Erica L. L.; Developmental & Reproductive BiologyTeratogens are chemicals that can cause birth defects in the developing embryo during pregnancy. Major structural birth defects affect 2-5% of children, but the etiology of this developmental error is often unknown. Exposure to teratogens (chemicals that cause birth defects) during gestation may play a causative role in many of these congenital defects. Therefore, it is important to identify teratogenic chemicals before pregnant women are exposed to them, but there is no easy, reliable test to determine potential teratogenicity of pharmaceutical drugs or industrial chemicals (pesticides, herbicides, solvents, etc.). Current developmental and reproductive toxicity (DART) testing uses millions of pregnant animals in outdated, inefficient regulatory studies. Embryonic stem cell-based in vitro tests (EST) produce faster, clearer results and have the potential to revolutionize DART testing, but they often lack the biologic complexity created during embryonic gastrulation and morphogenesis. The embryo is most sensitive to teratogenic exposures during the first three to eight weeks of fetal life. During this time, the process of morphogenesis shapes nearly all three-dimensional (3-D) organs and tissue structures in the embryo. Many of the common birth defects (e.g., neural tube closure defects and cardiac septal defects) are caused by disruptions in this vital process. Since morphogenesis drives the formation of fetal structures and is often affected by teratogenic drugs, a screen for potential teratogens should incorporate similar 3-D structural complexity, but this is a common deficit of in vitro teratogenicity tests. Aggregated P19C5 stem cells spontaneously form “embryoid bodies” (EBs) and recapitulate the germ layer differentiation and structural remodeling that occur during embryonic gastrulation and morphogenesis. Exposure to teratogens disrupts EB morphology, making P19C5 morphogenesis a sensitive indicator of developmental toxicity. In this research project, I validated the P19C5 system as a morphology-based teratogen-screening assay and demonstrate that the P19C5 assay can be used to investigate teratogenic mechanisms that cause structural defects. We expect that this test will allow us to accurately identify chemicals that may cause fetal malformations and help us understand the mechanisms of teratogenic chemicals in order to reduce the number of children born with preventable birth defects.Item Sox9 Driven Sex Determination in Mice with Limited Y Chromosome Gene Contribution(University of Hawaii at Manoa, 2018-05) Ortega, Egle A.; Developmental & Reproductive BiologyThe window of sex determination is a short but critical time during which sex fate of the embryo is decided depending on the chromosomal predisposition inherited from the parents. This genetic information guides the direction of gonadal sex development towards acquisition of anatomical male or female sexual characteristics. In most mammals, male sex determination is initiated by expression of the Y chromosome encoded Sry. The duration of SRY signaling is transient - just long enough to ensure upregulation of autosomally encoded Sox9. This way, SRY acts as a molecular switch that initiates differentiation of the bipotential gonad into a testis. However, once SRY signaling ceases, Sox9 remains at the center of male-specific molecular signaling profile that ensures masculinization of the genital ridges. The focus of my dissertation is on the effects of Sry-to-Sox9 replacement on the development of genital ridges, as well as spermatogenesis and fertility in adult males. Work presented here explores the hypothesis that transgenic overexpression of Sox9 can replace the function of endogenous Sry at the time of sex determination and can sufficiently support spermatogenesis and fertility in adult males. The sex-determining function of transgenic Sox9 was tested using two genetic models: (1) mice that carried X chromosome and Y chromosome lacking the endogenous Sry (XYTdym1); (2) mice that carried a single X chromosome and lacked all endogenous Y chromosome genes (XO). The progression of spermatogenesis in XYTdym1 males transgenic for Sox9 (XYTdym1Sox9) was assessed through various sperm and testicular analyses such as sperm counts, motility, and morphology evaluation, as well testis weight, shape, histology, vasculature assessment and mRNA expression levels. The fertility of XYTdym1Sox9 males was tested through fecundity trials and in vitro (IVF). These investigations revealed that despite some testicular abnormalities transgenic overexpression of Sox9 transgene in the context of YTdym1 can replace the function endogenous Sry and allows for sufficient levels of spermatogenesis and fertility. In the mouse only two Y chromosome genes were shown to be necessary for successful assisted reproduction: Sry and spermatogonial proliferation factor Eif2s3y. When Sry and Eif2s3y were transgenically added to mice carrying a single X chromosome (XO), these mice (XEif2s3yOSry) developed as phenotypic males and produced haploid gametes. The second part of my dissertation, focuses on replacement of Sry and Eif2s3y with their non Y chromosome encoded homologues, Sox9 and Eif2s3x. We found that males with Y chromosome genes limited to two (XEif2s3yOSry), one (XOSry,Eif2s3x and XEif2s3yOSox9) or none (XOSox9,Eif2s3x) can father offspring with assisted reproduction. However, we also observed that these males had various abnormalities of the seminiferous epithelium and testicular interstitium. Moreover, sometimes the gonads of the transgenic males resembled ovotestes and had elevated expression of ovarian markers. These findings led to a hypothesis that pathologies observed in males with limited Y chromosome genes arise at the time of sex determination due to altered signaling in the genital ridges. To test this hypothesis, I compared gonadal development in males without Y chromosome and in which sex determination is initiated either by Sry or Sox9, and spermatogenesis is driven by either Eif2s3y or Eif2s3x. My findings support the initial hypothesis and suggest that all XO males with limited Y chromosome genes have altered gonadal development at the critical time of sex determination. The failure to completely antagonize female specific signaling and establish characteristic male-like gonadal morphology is especially prominent in genotypes that have sex determination driven by transgenic overexpression of Sox9.